Free Lymphoma Workshops in Arizona and Massachusetts

On Saturday, March 6, 2010, Thomas P. Miller, MD, of the Arizona Cancer Center will welcome lymphoma patients, survivors, and loved ones to a one-day workshop at the Scottsdale Resort and Conference Center. The Lymphoma Research Foundation's Lymphoma Workshop programs provide the latest information about the diagnosis and treatment of lymphoma. Attendees will have an opportunity to learn more about their specific type of lymphoma during the comprehensive disease–specific breakout sessions

And, on Saturday April 17, 2010, a Lymphoma Workshop is also being held at the Sheraton Needham Hotel in Needham, Massachusetts from 8:00 AM – 2:00 PM. Lymphoma Workshop: Understanding Lymphoma Basics and Current Treatment Options has been carefully designed to provide patients, survivors and loved ones with information on a wide range of topics, including: lymphoma biology, understanding diagnostic tests, current therapeutic approaches and new therapies under investigation. In addition, special disease-specific breakout sessions include follicular non-Hodgkin lymphoma, aggressive non-Hodgkin lymphoma, mantle cell lymphoma, CLL/SLL, cutaneous lymphomas and Waldenstrom's macroglobulinemia. Other breakout sessions include managing treatment side effects, nutrition, information for newly diagnosed patients, stress management and legal issues surrounding cancer.

To register for either event, call (800) 500-9976 or visit www.lymphoma.org/azworkshop2010.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap